Arcadia Biosciences (RKDA) Equity Ratio (2014 - 2025)

Arcadia Biosciences has reported Equity Ratio for 12 years, with the latest figure at 0.63 in Q4 2025.

• For the quarter ending Q4 2025, Equity Ratio rose 37.37% year-over-year to 0.63; the trailing twelve-month figure through Dec 2025 stood at 0.63 (up 37.37% YoY), and the FY2025 full-year result was 0.63, up 37.37% from the prior year.
• Equity Ratio for Q4 2025 stood at 0.63, roughly flat from 0.63 in the prior quarter.
• The five-year high for Equity Ratio was 0.78 in Q1 2022, with the low at 0.46 in Q4 2024.
• Historically, Equity Ratio has averaged 0.66 across 5 years, with a median of 0.66 in 2023.
• Annual changes were most pronounced in 2021 — Equity Ratio soared 91.69% — and 2023, when it declined 29.58%.
• Arcadia Biosciences' Equity Ratio stood at 0.71 in 2021, then advanced by 1.73% to 0.72 in 2022, then slipped by 10.79% to 0.64 in 2023, then retreated by 28.58% to 0.46 in 2024, then surged by 37.37% to 0.63 in 2025.
• The last three Equity Ratio figures came in at 0.63 (Q4 2025), 0.63 (Q3 2025), and 0.58 (Q2 2025), per Business Quant data.